LISATA THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lisata Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Lisata Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$5.52M, a 19.7% increase year-over-year.
  • Lisata Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$24.1M, a 58.4% increase year-over-year.
  • Lisata Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$25.7M, a 55.4% increase from 2022.
  • Lisata Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$57.6M, a 98.3% decline from 2021.
  • Lisata Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$29.1M, a 51.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$24.1M -$5.52M +$1.35M +19.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$25.5M -$6.6M +$243K +3.55% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$25.7M -$6.03M +$516K +7.89% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$26.2M -$5.96M +$31.8M +84.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$58M -$6.88M -$155K -2.31% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$57.8M -$6.84M -$224K -3.38% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$57.6M -$6.54M +$308K +4.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$57.9M -$37.7M -$30.8M -441% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$27.2M -$6.72M +$427K +5.98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$27.6M -$6.62M +$1.47M +18.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$29.1M -$6.85M -$1.4M -25.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$27.6M -$6.97M -$1.62M -30.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$26M -$7.15M -$2.86M -66.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$23.2M -$8.09M -$4.03M -99.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$19.1M -$5.45M -$364K -7.16% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$18.8M -$5.35M -$278K -5.48% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$18.5M -$4.29M +$1.05M +19.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$19.6M -$4.06M +$535K +11.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$20.1M -$5.08M -$1.29M -33.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$18.8M -$5.07M -$1.31M -34.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$17.5M -$5.35M -$1.08M -25.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$16.4M -$4.59M +$567K +11% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$17M -$3.8M +$3.52M +48.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$20.5M -$3.76M +$2.37M +38.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$22.9M -$4.27M +$3.44M +44.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$26.3M -$5.16M +$1.27M +19.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$27.6M -$7.32M -$2.02M -38.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$25.6M -$6.13M -$402K -7.03% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$25.2M -$7.71M -$304K -4.11% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$24.9M -$6.43M +$4.64M +41.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$29.5M -$5.3M +$54.4M +91.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 -$83.9M -$5.73M +$4.66M +44.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$88.6M -$7.41M +$18.3M +71.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$107M -$11.1M +$7.01M +38.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$114M -$59.7M -$44.2M -284% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$69.7M -$10.4M +$5.88M +36.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$75.6M -$25.7M -$13.2M -107% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$62.3M -$18.1M -$4.59M -34% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$57.7M -$15.6M -$5.06M -48.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$52.7M -$16.3M -$6.95M -74.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$45.7M -$12.4M -$4.26M -52.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$41.5M -$13.5M -$4.67M -52.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$36.8M -$10.5M -$2.55M -32.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 -$34.3M -$9.31M -$1.22M -15.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 -$33M -$8.17M -$1.36M -19.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$31.7M -$8.83M -$1.29M -17.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$30.4M -$7.94M +$1.72M +17.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$32.1M -$8.09M -$859K -11.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$31.2M -$6.81M +$3.23M +32.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$34.5M -$7.54M -$467K -6.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$34M -$9.66M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 -$7.23M -$1.49M -25.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$10M -$6.54M -187% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$7.08M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$5.74M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$3.5M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.